Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Viramune Suspension*

Viramune Suspension* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Boehringer Ingelheim
Responsible Party Roxane Laboratories Inc
Origin U.S.A.
Manufacturer Roxane Laboratories Inc
Origin U.S.A.
ATC J05AG01

Your comment will appear shortly after approval

Viramune Suspension* :

Revision Date : 10/04/2014


Effect Frequency
Abdominal pain Common
ALT increased Common
Anaemia Uncommon
Anaphylactic reactions Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Common
Arthralgia (Pain joint) (Joint ache) Uncommon
AST increased Common
Autoimmune disorder Not known
Basedow's disease Not known
Blood alkaline phosphatase increased Not known
Blood bilirubin increased Not known
Blood phosphorus decreased Uncommon
Blood pressure increased Uncommon
Body fat disorder Not known
Breast enlargement Not known
Diarrhoea (Diarrhea) Common
DRESS (Drug reaction with eosinophilia and systemic symptoms) Uncommon
Eosinophilia Not known
Facial wasting Not known
Fat redistribution Not known
Fatigue Common
Gamma-GT increased Common
Granulocytopenia Common
Headache Common
Hepatic enzyme increased Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Not known
Hepatitis Common
Hepatitis fulminant Rare
Hepatorenal failure Rare
Hepatotoxicity (liver toxicity) Common
Hypercholesterolaemia Not known
Hyperglycaemia Not known
Hyperlactacidaemia Not known
Hypersensitivity Common
Hypertransaminasaemia Common
Hypertriglyceridaemia Not known
Immune reconstitution inflammatory syndrome Not known
Insulin resistance Not known
Jaundice Uncommon
Lipodystrophy acquired Not known
Lipohypertrophy Not known
Liver function test abnormal Common
Lyell Syndrome (Toxic epidermal necrolysis) Uncommon
Lymphadenopathy Not known
Maculopapular rash Not known
Myalgia Common
Nausea Common
Neuropathy peripheral Not known
Osteonecrosis Not known
Pancreatitis Not known
Pyrexia Common
Renal impairment Not known
Skin rash Very Common
Stevens-Johnson syndrome Uncommon
Thrombocytopenia (Thrombopenia) Not known
Transaminases increased Common
Urticaria Common
Vomiting Common

Different Units By MoH Code

Revision Date : 01/03/2017

Viramune Suspension*  MoH 2081 :
Form Oral suspension
Packaging Bottle
Package Size 240ml
Strength 50mg/5ml
NSSF ✘
Quarantine ✘
Reg. Number 974106/01
Submission date 01/01/2001
Registration Year 2006
Archived Date 2014


Price Comparison

● Country: Qatar
● Package Size: 240ml
● Public Price: 302 QAR ( 1,253,469.12 LBP )
● Pack size unit used: 240
● Cost/Unit: 1,2583 QAR ( 4,150.56 LBP )
● Pharmacy Price: 248.248338 QAR ( 1030369.6217693 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 240ml
● Public Price: 299 AED ( 1,229,177.04 LBP )
● Pack size unit used: 240
● Cost/Unit: 1,2458 AED ( 4,110.96 LBP )
● Pharmacy Price: 240.57 AED ( 988973.6472 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 240ml Plastic Bottle
● Public Price: 299 AED ( 1,229,177.04 LBP )
● Pack size unit used: 240
● Cost/Unit: 1,2458 AED ( 4,110.96 LBP )
● Pharmacy Price: 240.57 AED ( 988973.6472 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Sweden
● Package Size: 240ml
● Public Price: 499.13 SEK ( 898,488.90 LBP )
● Pack size unit used: 240
● Cost/Unit: 2,0797 SEK ( 3,600.22 LBP )
● Pharmacy Price: 444 SEK ( 799248.84 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: 240ml
● Public Price: 522.9 NOK ( 904,758.18 LBP )
● Pack size unit used: 240
● Cost/Unit: 2,1788 NOK ( 3,460.54 LBP )
● Pharmacy Price: 381.7 NOK ( 660444.059 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Withdrawn

● Country: UK
● Package Size: 240ml
● Public Price: 50.4 GBP ( 1,015,598.81 LBP )
● Pack size unit used: 240
● Cost/Unit: 0,21 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 240ml
● Public Price: 69.21 EUR ( 1,272,083.26 LBP )
● Pack size unit used: 240
● Cost/Unit: 0,2884 EUR ( 0.00 LBP )
● Pharmacy Price: 62.21 EUR ( 1143422.9105 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Spain
● Package Size: 240ml
● Public Price: 31.67 EUR ( 582,096.18 LBP )
● Pack size unit used: 240
● Cost/Unit: 0,132 EUR ( 0.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 240ml
● Public Price: 124.73 EUR ( 2,292,543.64 LBP )
● Pack size unit used: 240
● Cost/Unit: 0,5197 EUR ( 0.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 240ml
● Public Price: 65.18 EUR ( 1,198,011.66 LBP )
● Pack size unit used: 240
● Cost/Unit: 0,2716 EUR ( 0.00 LBP )
● Exfactory Price: 39.49 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 240ml
● Public Price: 26.42 EUR ( 485,600.92 LBP )
● Pack size unit used: 240
● Cost/Unit: 0,1101 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: France
● Package Size: 240ml
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 240 ml
● Exfactory Price: 203.55 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info